Why RWE programs fail under regulatory scrutiny — and what leaders can do about it
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
FDA has made its expectations for RWE clearer and more structured through recent guidance and...
by: Alexandra Miller, MPH Human papillomavirus (HPV) is one of the most common sexually...
Understanding PBC and today’s treatment landscape Primary biliary cholangitis (PBC) is a chronic...
As the new year begins, many patients refocus on weight management and long-term health goals. At...
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
Identifying the gaps in today’s real-world data The 2025 IMPACCT Real-World Evidence Summit brought...
Recently, HealthVerity COO and co-founder Andrew Goldberg spoke at a timely webinar: Back to...
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
AI agents are quickly becoming part of the clinical conversation. Since the release of large...
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
Real World Data (RWD) is increasingly being incorporated into healthcare and life science research to inform a myriad of decisions important to public health. However, the high stakes of these decisions are often undermined by a common challenge: acc...